Loading...
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
BACKGROUND: Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because they release large amounts of various mediators that sustain the inflammatory network. Masitinib, a sel...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3467179/ https://ncbi.nlm.nih.gov/pubmed/22691628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-12-36 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|